Toggle navigation
Home
Search
Services
Blog
Contact
About
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry
University of Illinois at Chicago, Chicago, IL, United States
Search 87 grants from Barry Levin
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Parent and Adolescent HIV/STD Risk Reduction Program
Role of Chemorepellants during Neural Crest Migration in the Eye
Frequency Nurses Engage in End-of-Life Discussions W/Patients and the Barriers
Residency Training in Gim and/OR Gp
SGER - Enhanced Sediment Transport due to Transient Wave Loads
Recently added grants:
Bio-Behavioral Core
Implementation Science and Health Outcomes Core
Quantifying the attentional template
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
Development Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN015352-001002
Application #
3617532
Study Section
Project Start
1991-09-30
Project End
Budget Start
1991-10-09
Budget End
1993-09-29
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1992
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
NIH 1992
N01 CN
Preclinical Toxicology Studies Ws#24 and #25
Levine, Barry S. / University of Illinois at Chicago
NIH 1991
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
Publications
Crowell, James A; Page, John G; Levine, Barry S et al.
(2006)
Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450.
Toxicol Appl Pharmacol 211:115-23
Comments
Be the first to comment on Barry Levin's grant